Title : [Survival analysis of different kinds of tyrosine kinase inhibitors in the treatment of patients with epidermal growth factor receptor mutated non-small cell lung cancer and leptomeningeal metastasis].

Pub. Date : 2022 Feb 15

PMID : 35144338






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Twenty-four patients developed disease progression on the first-and second EGFR-TKIs treatments, followed by treatment with the third-generation EGFR-TKIs (Osimertinib) in 12 cases, chemotherapy or anti-angiogenesis therapy in 4 cases, and the optimal supportive treatment in 8 cases. osimertinib epidermal growth factor receptor Homo sapiens